Clinical trial
Investigation of the Effects of Breakfast or Caffeine Containing Beverages on the Measurement of Plasma Chromogranin A in Patients With Gastro-entero-pancreatic Neuroendocrine Tumours (GEP-NET)
NCT03288402 is registered in ClinicalTrials.gov with University Hospitals Coventry and Warwickshire NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of the Effects of Breakfast or Caffeine Containing Beverages on the Measurement of Plasma Chromogranin A in Patients With Gastro-entero-pancreatic Neuroendocrine Tumours (GEP-NET)
- Lead sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 1, 2017
- Completion date
- February 10, 2022
- Enrollment
- 346 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.